Investing
704 Articles
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Thursday…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall St.research calls this Friday morning.…
We have many stocks on the move in the after-hours session. Today was the largest day for S&P earnings this…
Amgen Inc. (NASDAQ: AMGN) today announced financial results for the second quarter of 2012. The biotech giant’s results showed a…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall St. research calls this Wednesday…
Thursday was D-Day for the Supreme Court decision on the Obama healthcare mandate as to its constitutionality. The long and…
24/7 Wall St. loves companies which send capital back to shareholders via dividends. With all of the uncertainty in today’s…
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012…
When we issued our earnings previews for the week ahead, it looked as though Dendreon Corporation (NASDAQ: DNDN) had a…
Earnings season is in full swing and we have many key reports due in the coming week. 24/7 Wall St.…
AuthorDendreon Corp. (NASDAQ: DNDN), maker of prostate cancer drug Provenge, is once again rumored to be a takeover target. As…
You might have already heard the reports that Apple is sitting on a lot of cash, around the $100 billion…
The three major US equities indexes opened sharply lower this morning and the slide continued pretty much without interruption all…
Jon OggThese are some of this Tuesday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Amgen Inc.…
The Pharmaceutical Research and Manufacturers of America (PhRMA) has spoken out against the new 2013 budget proposed by President Obama. …
Our top personal finance-related articles today. Your wallet will thank you later.